10th Symposium

26/27 May 2017

Practical focus on the diagnosis and treatment of the psychiatric and neuropsychological aspects of HIV-infected patients.

Jose A. Muñoz-Moreno, Ph.D.

Lluita contra les Infeccions Foundation, Germans Trias i Pujol University Hospital. Barcelona, Spain

Measuring cognitive changes in HIV infection: Size really matters.

Ignacio Pérez-Valero, M.D., Ph.D.

Department of Infectious Diseases. Reina Sofia University Hospital. Córdoba, Spain

Pros and Cos of antiretroviral treatment on CNS.

Alan Winston, M.D.

HIV research unit. St. Mary’s Hospital. London, United Kingdom

Integrase inhibitors and the brain.

Johannes Schröder, Ph. D.

Section of Geriatric Psychiatry. University of Heidelberg. Germany.

Neurological soft signs in HIV associated neurocognitive disorder (HAND): an easy clinical examination for screening and early recognition.

Andrea Calcagno, M.D., DTM&H

Department of Medical Sciences, Unit of Infectious Diseases. University of Torino, Italy

Pharmacokinetic issues and CNS in HIV-infected patients.

Paola Cinque, M.D.

Infectious Diseases Unit of the IRCCS San Raffaele Hospital. Milan, Italy

Hot topics on CNS and HIV (most relevant presentations in conferences or articles published recently).

Scott Letendre, M.D.

UC San Diego Health’s Owen Clinic. University of California. San Diego, USA

Summary of the Symposium and discussion.

Risk behavior, effect on HIV-infection and neuropsychiatric

1-Practical training on diagnosis and management of clinical CNS problems in HIV-infected patients

Diagnosis and screening - Prevention and treatment of neurocognitive impairment in HIV-infected patients.

2-Practical training on diagnosis and management of clinical CNS problems in HIV-infected patients

Management of a HIV-infected patient with a psychiatric disorder

Oral Communications. Session 1

Oral Communications. Session 2